Summit Securities Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Buy
+1,173
New +$14.6K ﹤0.01% 606
2023
Q3
Sell
-278
Closed -$11K 1074
2023
Q2
$11K Sell
278
-143
-34% -$5.69K ﹤0.01% 771
2023
Q1
$17K Buy
421
+204
+94% +$7.49K ﹤0.01% 651
2022
Q4
$7K Sell
217
-95
-30% -$2.86K ﹤0.01% 1067
2022
Q3
$9K Sell
312
-137
-31% -$4.68K ﹤0.01% 802
2022
Q2
$16K Buy
449
+359
+399% +$14.5K ﹤0.01% 798
2022
Q1
$4K Buy
+90
New +$4.76K ﹤0.01% 1010
2017
Q3
Sell
-3,188
Closed -$207K 316
2017
Q2
$207K Sell
3,188
-3,646
-53% -$230K 0.04% 204
2017
Q1
$427K Buy
6,834
+549
+9% +$33K 0.12% 181
2016
Q4
$363K Buy
+6,285
New +$371K 0.08% 173

Other funds holding XRAY

Summit Securities Group's XRAY Position: Q1 2026 in Review

Summit Securities Group opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 1,173 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #606 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in XRAY as recently as Q2 2023.

Summit Securities Group first reported a position in XRAY in Q4 2016 and has held it in 10 quarters since. The position peaked at $427K in Q1 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Summit Securities Group held 1,173 shares of Dentsply Sirona worth $13.6K as of Q1 2026.
  • Dentsply Sirona was a new Summit Securities Group position in Q1 2026.
  • Dentsply Sirona made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #606 holding.
  • Summit Securities Group first reported a position in Dentsply Sirona in Q4 2016 and has held it in 10 quarters since.
  • Summit Securities Group's Dentsply Sirona position peaked at $427K in Q1 2017.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.